Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Diet Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 2 Motor Activity 2 Colorectal Neoplasms 2 Stomach Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Overweight 1 Obesity 1 Neoplasms 1 Melanoma 1 Malnutrition 1 Lung Neoplasms 1 Leukemia 1 Hypothalamic Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 GastroEsophageal Cancer 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Cachexia 1 Burkitt Lymphoma 1 Breast Carcinoma In Situ 1 Advanced Malignant Solid Neoplasm 1

Interventions

pembrolizumab 31 Blood Specimen Collection 29 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Cisplatin 11 atezolizumab 10 Drug Therapy 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Pemetrexed 8 Fluorouracil 8 olaparib 7 Trastuzumab 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 pertuzumab 6 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05441163 2025-06-24

ProActIF-01

Institut Curie

Phase NA Recruiting

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡